Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma

Annals of Surgery

Volumn 255, Issue 4, 2012, Pages 777-783

  Hartl, Dana M ^a   Leboulleux, Sophie ^a   Al Ghuzlan, Abir ^a   Baudin, Eric ^a   Chami, Linda ^a   Schlumberger, Martin ^a   Travagli, Jean Paul ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER PREVENTION; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; NERVE PARALYSIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RISK FACTOR; THYROID CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT;

EID: 84858650083     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31824b7b68     Document Type: Article

References (48)

1. Cooper DS, Doherty GM, Haugen BR, et al. The American Thyroid Association Guidelines Task Force. Revised management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-214.
2. Carty SE, Cooper DS, Doherty GM, et al. Consensus statement of the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19:1153-1158.
3. Robbins KT, Shaha AR,Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008;134:536-538. (Pubitemid 351724386)
4. Choi JS, Kim J, Kwak JY, et al. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. Am J Roentgenol. 2009;193:871-878.
5. Bonnet S, Hartl D, Leboulleux S, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab. 2009; 94:1162-1167.
6. Sobin LH, Gospodarowicz M, Wittekind C, eds. UICC International Union Against Cancer. TNMClassification ofMalignant Tumors. 7th ed.West Sussex, England: Wiley-Blackwell; 2010:58-62.
7. Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria for malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endorinol Metab. 2007;92:3590-3594. (Pubitemid 47435339)
8. HartlDM, Travagli JP.Central compartment neck dissection for thyroid cancer: a surgical technique. World J Surg. 2011;35:1553-1559.
9. Bhattacharyya N. The effects of more conservative neck dissections and radiotherapy on nodal yields from the neck. Arch Otolaryngol Head Neck Surg. 1998;124:412-416. (Pubitemid 28178312)
10. Shrime MG, Bachar G, Lea J, et al. Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck. 2009;31:1482-1488.
11. K̈ohler HF, Cunha IW, Kowalski LP. Impact of modified radical neck dissections on the number of retrieved nodes, recurrence and survival. Braz J Otorhinolaryngol. 2010;76:374-377.
12. Davidson HC, Park BJ, Johnson JT. Papillary thyroid cancer: controversies in the management of neck metastases. Laryngoscope. 2008;118:2161-2165.
13. Salter KD, Andersen PE, Cohen JI, et al. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality. Arch Otolaryngol Head Neck Surg. 2010;136:692-696.
14. Shen WT, Ogawa L, Ruan D, et al. Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predictingwhich patients will benefit. Surgery. 2010;148:398-403.
15. Chung YS, Kim JY, Bae JS, et al. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. Thyroid. 2009;19:241-246.
16. Hughes DT, White ML, Miller BS, et al. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery. 2010;148:1100-1107.
17. Moley JF, DeBenedetti MK. Patterns of nodalmetastases in palpablemedullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg. 1999;229:880-887.
18. Orloff LA. Central compartment lymphadenopathy: challenges presented by chronic lymphocytic thyroiditis. 14th International Thyroid Congress, Paris, France. September 11-16, 2010. Poster P-0675.
19. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroidmicrocarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399-407. (Pubitemid 38176456)
20. So YK, Son YI, Hong SD, et al. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery. 2010;148:526-531.
21. Ito Y, Jikuzono T, Higashiyama T, et al. Clinical significance of lymph node metastases of thyroid papillary carcinoma located in one lobe. World J Surg. 2006;30:1821-1828. (Pubitemid 44454993)
22. Lee YS, Lim YS, Lee JC, et al. Clinical implications of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. World J Surg. 2010;34:2558-2563.
23. Qubain SW,Nakamo S, BabaM, et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 2002;131:249-256. (Pubitemid 34229777)
24. K̈ohler HF, Kowalski LP. How many nodes are needed to stage a neck? A critical appraisal. Eur Arch Oto Rhino Laryngol. 2010;267:785-791.
25. Koo BS, Choi EC, Yoon YH, et al. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg. 2009;249:840-844.
26. Machens A, Holzhausen HJ, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg. 2004;139:43-45. (Pubitemid 38049617)
27. Mirallíe E, Visset J, Sagan C, et al. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg. 1999;23:970-974. (Pubitemid 29398483)
28. Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastases from thyroid cancer. Laryngoscope. 2010;121:487-491.
29. Morita S, Mizoguchi K, Suzuki M, Iizuka K. The accuracy of 18[F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography, ultrasonography and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma. World J Surg. 2010;34:2564-2569.
30. Ahn JE, Lee JH, Yi JS, et al. Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer. World J Surg. 2008;32:1552-1558.
31. Kim E, Park JS, Son KR, et al. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid. 2008;18:411-418. (Pubitemid 351519549)
32. Choi JS, Kim J, Kwak JY, et al. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. Am J Roentgenol. 2009;193:871-878.
33. Zetoune T, Keutgen X, Buitrago D, et al. Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol. 2010;17:3287-3293.
34. Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastasis and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005,90:5723-5729. (Pubitemid 41415482)
35. Bardet S, Malville E, Rame JP, et al. Macroscopic lymph node involvement and neck dissection predict lymph node recurrence in papillary thyroid carcinoma. Eur J Endocrinol. 2008;158:551-560. (Pubitemid 351606351)
36. Mazzaferri EL, Doherty GM, Steward DL. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid. 2009;19:683-689.
37. SywakM,Comford L, Roach P, et al.Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery. 2006;140:1000-1005.
38. Durante C, Haddy N, Baudin E, et al. Long term outcome of 444 patients with distantmetastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892-2899. (Pubitemid 44271732)
39. White Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2007;31:895-904. (Pubitemid 46716783)
40. Scheumann GFW, Gimm O,Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994;18:559-568. (Pubitemid 24273857)
41. Shen WT, Ogawa L, Ruan D, et al. Central neck lymph node dissection for papillary cancer. Arch Surg. 2010;145:272-275.
42. Tisell LE, NilssonB,Molne J, et al. Improved survival of patientswith papillary thyroid cancer after surgical microdissection. World J Surg. 1996;20:854-859. (Pubitemid 26281914)
43. Salvesen H, Njolstad PR, Akslen LA, et al. Thyroid carcinoma: results from surgical treatment in 211 consecutive patients. Eur J Surg. 1991;157:521-526.
44. Roh JL, Park JY, Park C. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: patterns of nodal metastais, morbidity, recurrence, postoperative levels of serumparathyroid hormone. Ann Surg. 2007;245:604-610. (Pubitemid 46555665)
45. Nascimento C, Borget I, Al Ghuzlan A, et al. Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level. Endocr Relat Cancer. 2011;18:R29-R40.
46. Tuttle RM, Tala H, Shah J, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010;12:1341-1349.
47. Cunningham DK, Yao KA, Turner RR, et al. Sentinel node biopsy for papillary thyroid cancer: 12 years of experience at a single institution. Ann Surg Oncol. 2010;17:2970-2975.
48. Anand SM, Gologan O, Rochon L, et al. The role of sentinel lymph node biopsy in differentiated thyroid carcinoma. Acta Otolaryngol Head Neck Surg. 2009;135:1199-1204.